Who is the mastermind behind the RM24 million health product syndicate?

Question

Accepted Answer

The mastermind behind the RM24 million health product syndicate is a 34-year-old local man.

A 34-year-old local man has been identified as the individual coordinating the operations for a syndicate involved in the production and distribution of unregistered health products. This syndicate operated across 19 premises in Penang, with seized goods valued at RM24 million. The illicit activities are believed to have been ongoing since 2020, with the syndicate employing a strategy of decentralising its production processes across multiple locations to avoid detection by authorities.
Syndicate Operations and Seizures

The integrated operation, which began on January 26, targeted 19 premises involved in the illegal trade of unregistered health products. Authorities seized a significant quantity of items, including 88,000 units of unregistered health products, over 500 packages of raw materials suspected of containing scheduled poisons, and more than 23,000 semi-finished products. Additionally, two digital devices and 36 medicine-processing machinery units, such as capsule-filling and strip-packaging machines, were confiscated.
Nature of Illicit Products

The seized products included traditional Chinese medicines suspected of containing prohibited substances like steroids, paracetamol, and allopurinol, all of which are listed under the Poisons Act 1952. These products were primarily marketed as painkillers and treatments for conditions such as gout, with an estimated retail price of RM20 per box. Investigations revealed that the same ingredients were used across various products, often under different labels.
International Reach and Evasion Tactics

Beyond the domestic market, the syndicate is also believed to have used its facilities to produce medicines intended for export to Vietnam. To evade detection, the syndicate deliberately dispersed its production processes across multiple locations. The raided factory in Simpang Ampat was identified as the largest facility and accounted for the bulk of the seizure's value. Although some premises were registered as processing facilities, they lacked the necessary licenses for medicine manufacturing and operated only on selected days to avoid regulatory scrutiny.

Reading history

Hide →

This history is cleared when the page is closed.

Who is the mastermind behind the RM24 million health product syndicate?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends